Journal Logo

Latest Articles

Article

Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial

Harrison, Claire N.; Schaap, Nicolaas; Vannucchi, Alessandro M.; More

April 29, 2021

Guideline Article - Expert opinion

Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm

Baronciani, Donatella; Casale, Maddalena; De Franceschi, Lucia; More

April 29, 2021

Article

Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial

Mesa, Ruben A.; Schaap, Nicolaas; Vannucchi, Alessandro M.; More

April 29, 2021

Article

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant

Holthof, Lisa C.; Stikvoort, Arwen; van der Horst, Hilma J.; More

April 21, 2021